Projects undertaken by Department of Pharmacoinformatics

Ongoing projects
Government
1.	Establishment of a Bioinformatics Centre for Metabolism and Toxicity - BIC at National Institute of Pharmaceutical Education And Research (NIPER), Mohali, funded by Department of Biotechnology* (sanction no. BT/PR40164/BTIS/137/17/2021 dated 11-03-2021*).
2.	In silico, Biochemical and Structural Characterization of the Mycobacterium tuberculosis (M.tb) elongation factors (EF-Tu, EF-Ts and EF-G), funded by Indian Council of Medical Research* (sanction no. ISRM/12(24)/2020 dated 07-01-2021*).
Completed projects
Government
1.	OSDD chemoinformatics, funded by Council of Scientific and Industrial Research
2.	Studies on PTP1B allosteric inhibitors: in silico design, biological applications and protein crystallization, funded by Council of Scientific and Industrial Research* (sanction no. 37/(1617)/13/EMR-II dated 07-10-2013*).
3.	The challenges for new drug discovery for oral anti diabetic drugs: Molecular dynamics simulations, pharmacophore modeling and molecular design of PTP1B allosteric inhibitors, funded by Science and Engineering Research Board, DST* (sanction no. SERB/F/3079/2013-2014 dated 13-08-2013*).
4.	Divalent N(I) compounds among therapeutic agents: An electronic structure and reactivity study, funded by Science and Engineering Research Board, DST* (sanction no. SB/S1/PC-96/2012 dated 27-07-2024*).
5.	Molecular property diagnostic suite (MPDS): An OSDD chemoinformatics portal, funded by Council of Scientific and Industrial Research* (sanction no. OSDD/HCP0001/12FYP/2012-13/Fin/2415 dated 27-07-2024*).
6.	Identification of novel inhibitors targeting Epidermal Growth Factor Receptor using structure and ligand based approach, funded by
7.	In silico investigation of Mechanism based inhibition of CYPs, funded by Department of Biotechnology* (sanction no. BT/PR14837/BID/07/348/2010 dated 27-07-2024*).
8.	Molecular Dynamics Studies of the Homology Model of CYP1A1, Structure Based Drug Design and Virtual Screening of Potential Ligands that Modulates th Biological Functions of CYP1A1, funded by Department of Biotechnology* (sanction no. BT/PR/14979/BID/07/353/2010 dated 27-07-2024*).
9.	In Silico Prediction of Blood Brain Barrier Permeability Using Artificial Intelligence, funded by Department of Electronics and Information Technology, GOI* (sanction no. DIT/R&D/Bio/15(3)/2011 dated 10-02-2012*).
10.	Design and Synthesis of Novel Y-shaped PPARy Activators, funded by Council of Scientific and Industrial Research* (sanction no. 02(0042)/11/EMR-II dated 01-01-2012*).
11.	Investigations of the solid-state properties of Pharmaceutical solids by in silico approaches, funded by Council of Scientific and Industrial Research* (sanction no. 01/(2495)/11/EMR-II dated 27-07-2024*).
12.	Design and Pharmaceutical profiling of anti-inflammatory leads: small molecule approaches, funded by Department of Science and Technology* (sanction no. SR/FT/CS-018/2010 dated 27-07-2024*).
13.	Computer Aided Design of selective and specific Aldose Reductase (ALR2) Inhibitors for treatment of diabetic complications, funded by Council of Scientific and Industrial Research* (sanction no. 27(0230)/10/EMR-II dated 31-05-2010*).
14.	S-oxidation by Enzymes: Computation Study on the metabolism of the drugs with sulfide unit, funded by Department of Science and Technology* (sanction no. SR/S1/PC-66/2008 dated 27-07-2024*).
15.	In Silico Prediction of Subcellular Localization using Artificial Intelligence, funded by Department of Electronics and Information Technology, GOI* (sanction no. DIT/R&D/BIO/15(21)/2008 dated 25-06-2009*).
16.	Computer Aided Design of Dendrimeric Nanoparticle for Anti-Diabetic Drug Delivery, funded by Department of Science and Technology* (sanction no. SR/NM/NS-32/2008 dated 27-07-2024*).
17.	Probing the mechanism and structural requirement for CCR2 antagonism: Computer Aided Molecular Design of Novel Potent and small CCR2 Antagonists for Inflammation Driven Diseases, funded by Council of Scientific and Industrial Research* (sanction no. 01(2242)/08/EMR-II dated 13-08-2013*).
18.	Modeling and Informatics in Drug Design, SERC Summer School, funded by Department of Science and Technology
19.	Directory of R & D Capabilities In the Field of Tuberculosis, funded by National Science and Technology Management Information System* (sanction no. DST/NSTMIS/05/101/200708 dated 25-04-2008*).
20.	Development of an In Silico Model For Prediction of the HIV-1 Integrase Inhibitory Activity and Biological Evaluation of the Predicted Molecules, funded by Department of Biotechnology* (sanction no. BT/PR7130/BID/07/186/2006 dated 24-09-2007*).
21.	Molecular Modelling Studies To Design Selctive Glycogen Synthase Kinase-3 Inhibitors, funded by Department of Science and Technology* (sanction no. SR/FTP/CS-38/2006 dated 06-07-2006*).
22.	Bioinformatics Infrastructure Facility, funded by Department of Biotechnology* (sanction no. BT/BI/04/055/2001 dated 06-11-2006*).
23.	Structural Bioinformatics For Effective and Efficient Drug Discovery :BIONFARM, funded by Department of Biotechnology* (sanction no. BT/IN/Finland/CGM/2006 dated 01-09-2006*).
24.	Targeting Oxidative Stress-Advanced Glycation End Products Pathways In Diabetic Neuropathy/ Development of Novel Anti Parasitic Agents Design and Synthesis, funded by
25.	Development of Packing Material Norms, funded by National Pharmaceutical Pricing Authority, GOI
26.	Molecular Modelling Studies on the Dual Activators of PPARa and PPARy, funded by Council of Scientific and Industrial Research* (sanction no. 01/(2029)/05/EMR-II dated 15-12-2005*).
27.	Pharmacoinformatics Workshop, funded by Ministry of Chemical and Fertilizers* (sanction no. 16012/2005-Ch-II dated 18-03-2005*).
28.	Pharmaceutical Education and Practicing Pharmacist Information System, funded by National Science and Technology Management Information System* (sanction no. DST/NSTMIS/05/59/2004-05 dated 28-01-2005*).
29.	Computer Aided Design of Protein Tyrosine Phosphates 1B (PTP1B) Inhibitors as Oral Anti Diabetic Agents, funded by Department of Science and Technology
30.	Setting up of National Facility on Pharmacoinformatics, funded by Department of Science and Technology* (sanction no. VII-PRDSF/14/04-05-TT dated 01-11-2005*).
31.	Molecular Modelling Studies on the Nitric Oxide Releasing Drugs, funded by Department of Science and Technology* (sanction no. SR/S1/PC-29/2003 dated 28-07-2004*).
32.	Nmitli (Team India) Effort In Devepoling A Versaltile, Portable Software Suite For Bioinformatics, funded by
33.	Molecular Modelling Studies on the Organosulfur Compounds With S N Bonds, funded by
Sponsored
34.	To carry out project of Eli Lilly, Indianapolis by the CADD lab of the Medicinal Chemistry of NIPER., funded by Eli Lilly, Indianapolis by the CADD lab
35.	For conducting the 3rd CRSI mid-year-symposium on 25th and 26th July 2008, funded by CRSI
36.	For CADD work under the Industry, funded by Torrent Pharmaceutical Ltd. Ahemedabad
37.	Impact of TRIPS on Pharmaceutical Prices, funded by World Health Organization
Consultancy
38.	Upgradation of Formulation Database from ORG March 2006 data, funded by National Pharmaceutical Pricing Authority, GOI
39.	Upgradation of Formulation Database from ORG March 2005 data, funded by National Pharmaceutical Pricing Authority, GOI
40.	Growth rate of therapeutic segments & APIs in India, funded by Unimark Remedies Limited, Ahmedabad
41.	Upgradation of Formulation Database from ORG March 2004 data, funded by National Pharmaceutical Pricing Authority, GOI
42.	Upgradation of Formulation Database from ORG March 2003 data, funded by National Pharmaceutical Pricing Authority, GOI
43.	Upgradation of Formulation Database from ORG March 2002 data, funded by National Pharmaceutical Pricing Authority, GOI
44.	Development of formulation database from ORG-IMS, funded by National Pharmaceutical Pricing Authority, GOI
45.	ITC (HS) classification of drugs, drug intermediates and formulations, funded by National Pharmaceutical Pricing Authority, GOI